medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2025, Number 4

<< Back Next >>

Rev Latin Infect Pediatr 2025; 38 (4)

Clinical and microbiological characterization of bacteremias in pediatric hematological-oncological patients

Enríquez GEV, Morayta RCARR, Martínez BME, Minero HMÁ, Ordóñez OJ

Language: Spanish
References: 26
Page: 141-149
PDF size: 331.12 Kb.


ABSTRACT

Among patients with hematologic malignancies, bacteremia is a frequent occurrence, significantly increasing mortality. Therefore, targeted monitoring and follow-up can optimize their treatment. The use of invasive devices in these patients increases the incidence of Gram-positive infections. Currently, Gram-negative bacilli, often multidrug-resistant, are also frequently observed, suggesting that these are additional infections. However, this still needs to be confirmed in each hospital setting, as the infectious etiology can vary depending on local and regional epidemiological conditions and even the clinical characteristics of the patients with hematologic malignancies. Therefore, we propose the characterization the microorganisms to identify the epidemiologic conditions, and the areas of improvement to stablish improvement care strategies for this population.


REFERENCES

  1. Torres HA, García GA, Pradere PJC, Rives Y, Fernández CE. Bacteriemias en la unidad de cuidados intensivos. Revista Cubana de Medicina Militar. 2019; 48 (1).

  2. Acuña M, O'Ryan M, Cofré J, Alvarez I, Benadof D, Rodríguez P et al. Differential time to positivity and quantitative cultures for noninvasive diagnosis of catheter-related blood stream infection in children. Pediatr Infect Dis J. 2008; 27 (8): 681-685.

  3. Riedel S, Bourbeau P, Swartz B, Brecher S, Carroll KC, Stamper PD et al. Timing of specimen collection for blood cultures from febrile patients with bacteremia. J Clin Microbiol. 2008; 46 (4): 1381-1385.

  4. Murray PR, Rosenthal KS, Pfaller MA. Microbiología médica, 9a ed. España: Editorial Elsevier 2021.

  5. Mermel L, Allon M, Bouza E, Craven D, Flynn P, O'Grady N, et al. Clinical Practice: Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009; 49(1): 1-45.

  6. Braun E, Hussein K, Geffen Y, Rabino G, Bar-Lavie Y, Paul M. Predominance of Gram-negative bacilli among patients with catheter-related bloodstream infections. Clin Microbiol Infect. 2014; 20 (10): O627-629.

  7. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol. 2000; 21 (8): 510-515.

  8. Deen J, von Seidlein L, Andersen F, Elle N, White NJ, Lubell Y. Community-acquired bacterial bloodstream infections in developing countries in south and southeast Asia: a systematic review. Lancet Infect Dis. 2012; 12 (6): 480-487.

  9. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004; 32 (3): 858-873. doi: 10.1097/01.ccm.0000117317.18092.e4. Erratum in: Crit Care Med. 2004; 32 (6): 1448.

  10. Abrutyn E, Goldmann DA, Scheckler WE. Saunders infection control reference service, 2nd ed. Philadelphia PA; WB Saunders; 2000.

  11. Dripps RD. New classification of physical status. Anesthesiol. 1963; 24: 111.

  12. Yadegarynia D, Tarrand J, Raad I, Ralston K. Current spectrum of bacterial infections in patients with cancer. Clin Infect Dis. 2003; 37 (8): 1144-5.

  13. Wyllie DH, Bowler IC, Peto TE. Relation between lymphopenia and bacteraemia in UK adults with medical emergencies. J Clin Pathol. 2004; 57 (9): 950-955.

  14. De Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink J, van der Poll T, Wever PC. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care. 2010; 14 (5): R192.

  15. Bass DA, Gonwa TA, Szejda P, Cousart MS, DeChatelet LR, McCall CE. Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest. 1980; 65 (6): 1265-1271.

  16. Weller PF. Eosinophilia. Rich RR editor. Clinical immunology principles and practice. St Louis: Mosby Year Book, 1996, pp. 1022-1031.

  17. Lodise TP Jr, Patel N, Kwa A, Graves J, Furuno JP, Graffunder E et al. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother. 2007; 51 (10): 3510-3515.

  18. Arendrup MC, Sulim S, Holm A, Nielsen L, Nielsen SD, Knudsen JD et al. Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol. 2011; 49 (9): 3300-3308.

  19. Byl B, Clevenbergh P, Jacobs F, Struelens MJ, Zech F, Kentos A et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis. 1999; 29 (1): 60-66; discussion 67-68.

  20. Velasco E, Byington R, Martins CS, Schirmer M, Dias LC, Goncalves VM. Bloodstream infection surveillance in a cancer centre: a prospective look at clinical microbiology aspects. Clin Microbiol Infect. 2004; 10 (6): 542-549. doi: 10.1111/j.1469-0691.2004.00874.x.

  21. Mikulska M, Viscoli C, Orasch C, Livermore DM, Averbuch D, Cordonnier C et al. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. J Infect. 2014; 68 (4): 321-331. doi: 10.1016/j.jinf.2013.12.006.

  22. Hagag AA, Hassan SM, Elgamasy MA, Afifi IK. Study of common bacterial and fungal pathogens in children with hematological malignancies during febrile neutropenia: single center Egyptian study. Infect Disord Drug Targets. 2016; 16 (1): 54-62. doi: 10.2174/1871526516666151230124333.

  23. Chen S, Liu S, Yuan X, Mai H, Lin J, Wen F. Etiology, drug sensitivity profiles and clinical outcome of bloodstream infections: A retrospective study of 784 pediatric patients with hematological and neoplastic diseases. Pediatr Hematol Oncol. 2019; 36 (8): 482-493. doi: 10.1080/08880018.2019.1667462.

  24. Garrido MM, Garrido RQ, Cunha TN, Ehrlich S, Martins IS. Comparison of epidemiological, clinical and microbiological characteristics of bloodstream infection in children with solid tumours and haematological malignancies. Epidemiol Infect. 2019; 147: e298. doi: 10.1017/S0950268819001845.

  25. Zhu GQ, Xu CH, Lin QS, Wang XX, Wang LL, Zhao NN et al. [Analysis of pathogens and clinical characteristics of bloodstream infection in neutropenic children with hematological malignancies from 2014 to 2018]. Zhonghua Xue Ye Xue Za Zhi. 2020; 41 (8): 655-660. Chinese. doi: 10.3760/cma.j.issn.0253-2727.2020.08.007.

  26. Sfetsiori AE, Doganis D, Doudoulakakis A, Spyridis N, Pourtsidis A, Servitzoglou M, Nikita M, Papachristidou S, Magkou E, Dana H, Lebessi E, Kosmidis H, Baka M, Tsolia M. Predictive factors for gram-negative versus gram-positive bloodstream infections in children with cancer. J Pediatr Hematol Oncol. 2022; 44 (2): e368-e373. doi: 10.1097/MPH.0000000000002253.




2020     |     www.medigraphic.com